Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2024International Journal of Research in Medical SciencesOpen Access

Understanding the factors influencing pharmacokinetics of tacrolimus

View Full Paper
Ask AI
Bookmark
Share

Authors

VSV SivakumarMRM. RakshnaMSM. S. Soorya

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sivakumar et al. (2024) studied this question.

synapsesocial.com/papers/68e6cc04b6db64358764a4ebhttps://doi.org/10.18203/2320-6012.ijrms20241273
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients2026
  2. 2Guiding the starting dose of the once-daily formulation of tacrolimus in “de novo” adult renal transplant patients: a population approach2024 · 3 citations
  3. 3Distribution of CYP3A4 and CYP3A5 Polymorphisms and Genotype Combination Implicated in Tacrolimus Metabolism2024 · 2 citations
  4. 4Personalized tacrolimus therapy in allogeneic hematopoietic stem cell transplantation: from pharmacokinetic variability to novel control strategies.2026
  5. 5CYP3A4*18B, CYP3A5*3, and MDR1C3435T gene studies with tacrolimus pharmacokinetics in healthy Chinese subjects2024 · 2 citations